FBL-MTX ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05117593
(ClinicalTrials.gov)
June 28, 202123/9/2021Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTXPhase 1 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single-Ascending Doses of FBL-MTX in Healthy SubjectsRheumatoid ArthritisDrug: FBL-MTX;Drug: PlaceboSOLFARCOS - Pharmaceutical and Cosmetic Solutions LtdNULLCompleted18 Years55 YearsAll32Phase 1Portugal